Cargando…

Incremental increases in economic burden parallels cardiometabolic risk factors in the US

OBJECTIVE: Estimate the economic burden associated with incremental increases in the number of cardiometabolic risk factors (CMRFs) in the US. METHODS: We used the nationally representative Medical Expenditure Panel Survey from 2010 to 2012 to create a retrospective cohort of people based on the num...

Descripción completa

Detalles Bibliográficos
Autores principales:	McQueen, R Brett, Ghushchyan, Vahram, Olufade, Temitope, Sheehan, John J, Nair, Kavita V, Saseen, Joseph J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4976812/ https://www.ncbi.nlm.nih.gov/pubmed/27536152 http://dx.doi.org/10.2147/DMSO.S106809

Ejemplares similares

Indirect and direct costs of acute coronary syndromes with comorbid atrial fibrillation, heart failure, or both
por: Ghushchyan, Vahram, et al.
Publicado: (2014)

Costs and outcomes associated with clopidogrel discontinuation in Medicare beneficiaries with acute coronary syndrome in the coverage gap
por: Page, Robert Lee, et al.
Publicado: (2012)

An evaluation of the impact of patient cost sharing for antihypertensive medications on adherence, medication and health care utilization, and expenditures
por: Pesa, Jacqueline A, et al.
Publicado: (2012)

Adverse event rates and economic burden associated with purine nucleoside analogs in patients with hairy cell leukemia: a US population-retrospective claims analysis
por: Epperla, Narendranath, et al.
Publicado: (2020)

Understanding barriers to medication adherence in the hypertensive population by evaluating responses to a telephone survey
por: Nair, Kavita V, et al.
Publicado: (2011)

The cost of inpatient death associated with acute coronary syndrome
por: Page, Robert L, et al.
Publicado: (2016)

Incremental Health Care Resource Utilization and Economic Burden of Venous Thromboembolism Recurrence from a U.S. Payer Perspective
por: Lin, J., et al.
Publicado: (2014)

Persistent Symptoms of Dengue: Estimates of the Incremental Disease and Economic Burden in Mexico
por: Tiga, D. Carolina, et al.
Publicado: (2016)

Association of incremental pulse wave velocity with cardiometabolic risk factors
por: Nabeel, P. M., et al.
Publicado: (2021)

Cost-effectiveness of continuous glucose monitoring and intensive insulin therapy for type 1 diabetes
por: McQueen, R Brett, et al.
Publicado: (2011)

The incremental economic burden of heart failure: A population-based investigation from South Korea
por: Cho, Hyeonseok, et al.
Publicado: (2018)

On the Accuracy and Parallelism of GPGPU-Powered Incremental Clustering Algorithms
por: Chen, Chunlei, et al.
Publicado: (2017)

Initiation Patterns of Statins in the 2 Years After Release of the 2013 American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Management Guideline in a Large US Health Plan
por: Olufade, Temitope, et al.
Publicado: (2017)

Missed Opportunities for Providing Low-Fat Dietary Advice to People With Diabetes
por: Lobo, Ingrid E., et al.
Publicado: (2012)

Incremental economic burden associated with exudative age-related macular degeneration: a population-based study
por: Kim, Siin, et al.
Publicado: (2019)

Complications and Health Care Resource Utilization Associated with Systemic Corticosteroids in Children and Adolescents with Persistent Asthma
por: Sullivan, Patrick W., et al.
Publicado: (2020)

Framework for Patient Experience Value Elements in Rare Disease: A Case Study Demonstrating the Applicability of Combined Qualitative and Quantitative Methods
por: McQueen, R. Brett, et al.
Publicado: (2022)

US Integrated Delivery Networks Perspective on Economic Burden of Patients with Treatment-Resistant Depression: A Retrospective Matched-Cohort Study
por: Pilon, Dominic, et al.
Publicado: (2019)

Incremental and Parallel Machine Learning Algorithms With Automated Learning Rate Adjustments
por: Hishinuma, Kazuhiro, et al.
Publicado: (2019)

Imaging in gout - What can we learn from MRI, CT, DECT and US?
por: McQueen, Fiona M, et al.
Publicado: (2011)

Current and projected future economic burden of Parkinson’s disease in the U.S.
por: Yang, Wenya, et al.
Publicado: (2020)

Economic Burden of Osteoporosis-Related Fractures in the US Medicare Population
por: Williams, Setareh A., et al.
Publicado: (2020)

A parallel and incremental algorithm for efficient unique signature discovery on DNA databases
por: Lee, Hsiao Ping, et al.
Publicado: (2010)

Economic burden of asthma in Singapore
por: Finkelstein, Eric A, et al.
Publicado: (2021)

Patient-reported barriers to osteoporosis therapy
por: Lindsay, Brianna R., et al.
Publicado: (2016)

Incremental healthcare cost burden in patients with atrial flutter only
por: Kim, Kathryn M., et al.
Publicado: (2023)

Incremental innovations in operation theaters
por: Tagare, Shivraj, et al.
Publicado: (2023)

Maternal and Pregnancy Related Predictors of Cardiometabolic Traits in Newborns
por: Morrison, Katherine M., et al.
Publicado: (2013)

Characteristics and Incidence of Concussion Among a US Collegiate Undergraduate Population
por: Breck, John, et al.
Publicado: (2019)

The Effectiveness and Value of Rivaroxaban and Icosapent Ethyl as Additive Therapies for Cardiovascular Disease: A Summary from the Institute for Clinical and Economic Review’s Midwest Comparative Effectiveness Public Advisory Council
por: Synnott, Patricia G., et al.
Publicado: (2020)

Expanding the Role of the Patient-Centered Outcomes Research Institute: Reauthorization and Facilitating Value Assessments
por: Padula, William V., et al.
Publicado: (2019)

Toward Modified Impact Inventory Tables to Facilitate Patient-Centered Value Assessment
por: McQueen, R. Brett, et al.
Publicado: (2021)

The economic burden of pulmonary arterial hypertension (PAH) in the US on payers and patients
por: Sikirica, Mirko, et al.
Publicado: (2014)

Economic Burden of Postoperative Neurocognitive Disorders Among US Medicare Patients
por: Boone, M. Dustin, et al.
Publicado: (2020)

Economic burden of hemophilia B in the US: a systematic literature review
por: Li, Nanxin (Nick), et al.
Publicado: (2019)

Economic Burden of Growth Hormone Deficiency in a US Pediatric Population
por: Kaplowitz, Paul B, et al.
Publicado: (2021)

Economic burden of growth hormone deficiency in a US pediatric population
por: Kaplowitz, Paul, et al.
Publicado: (2021)

Anti B-cell maturation antigen CAR T-cell and antibody drug conjugate therapy for heavily pretreated relapsed and refractory multiple myeloma: A summary from the Institute for Clinical and Economic Review’s Midwest Comparative Effectiveness Public Advisory Council
por: Beinfeld, Molly, et al.
Publicado: (2021)

The incremental burden of pain in patients with depression: results of a Japanese survey
por: Vietri, Jeffrey, et al.
Publicado: (2015)

Scar burden is an independent and incremental predictor of cardiac resynchronisation therapy response
por: Harb, Serge C, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_112m7g350cajck3b473hbc7660